Finzati - Logo
CNXC logo

Concentrix Corporation

CNXC • Information Technology Services
$32.16
▼ -0.69 (-2.10%)
Current price
EarningsLatest report: Feb 28, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$1.97B
Growth
19.1%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 9.4%Positive free cash flow · 9.09Consistent free cash flow · 5/5Healthy liquidity · 1.4Weak profitability
Financial data as of: Feb 28, 2026, 12:00 AM UTCLast earnings update: Mar 24, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$32.16
Change-2.10%
Shares Out61.30M
Market Cap$1.97B
Enterprise Value$6.49B
52W Range19.12 - 62.14
Beta0.45
P/E-1.48
P/S0.20
P/B0.71
P/FCF4.07
EV/Sales0.65

Investment DNA

How strong this company looks for long-term investors

68
out of 100
Business Quality
Margins, moat, returns
29/100
Financial Strength
Debt, cash, stability
55/100
Growth Potential
Revenue and expansion
83/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 9.4%Positive free cash flow · 9.09Consistent free cash flow · 5/5Healthy liquidity · 1.4Weak profitability

Analyst view

Analyst sentiment and price target

CNXC
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
89/100
Bullish
Bullish
7
Hold
2
Bearish
0
Price Target
2026-07-08
Low
$30.00
Mean
$35.00
Median
$30.00
High
$45.00

Company Overview

IPO: 11/24/2020
Industry: Information Technology Services
P/B i: 0.71
Debt / Equity i: 1.69
Operating Margin: 6.20%
Net Margin: -13.02%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: 1.69
Current Ratio: 1.40
Quick Ratio: 1.40
Status: Moderate

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Groupe Bruxelles Lambert
Transaction: 04/29/2026
SELL
Change
-6,000,000
Price
$22.25
Filing
05/01/2026
Type
SELL
Valentine Andre S
Transaction: 04/09/2026
BUY
Change
+2,500
Price
$27.95
Filing
04/09/2026
Type
BUY
Caldwell Christopher A
Transaction: 03/26/2026
BUY
Change
+1,000
Price
$26.97
Filing
03/30/2026
Type
BUY